These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 17008284

  • 1. Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population.
    Zaatari GS, Otrock ZK, Sabbagh AS, Mahfouz RA.
    Pathology; 2006 Oct; 38(5):442-4. PubMed ID: 17008284
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M.
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [Abstract] [Full Text] [Related]

  • 6. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
    Margaglione M, Bossone A, Coalizzo D, D'Andrea G, Brancaccio V, Ciampa A, Grandone E, Di MG.
    Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
    [Abstract] [Full Text] [Related]

  • 7. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G.
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [Abstract] [Full Text] [Related]

  • 8. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T.
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [Abstract] [Full Text] [Related]

  • 9. The HR2 haplotype of factor V is not associated with the risk of myocardial infarction.
    Doggen CJ, de Visser MC, Vos HL, Bertina RM, Cats VM, Rosendaal FR.
    Thromb Haemost; 2000 Nov; 84(5):815-8. PubMed ID: 11127862
    [Abstract] [Full Text] [Related]

  • 10. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N, Kruthika-Vinod TP, Christopher R.
    Thromb Res; 2007 Nov; 119(4):497-500. PubMed ID: 16781765
    [Abstract] [Full Text] [Related]

  • 11. Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism.
    Benson JM, Ellingsen D, El-Jamil M, Jenkins M, Miller CH, Dilley A, Evatt BL, Hooper WC.
    Thromb Haemost; 2001 Nov; 86(5):1188-92. PubMed ID: 11816705
    [Abstract] [Full Text] [Related]

  • 12. HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait.
    Jadaon MM, Dashti AA.
    J Thromb Haemost; 2005 Jul; 3(7):1467-71. PubMed ID: 15978104
    [Abstract] [Full Text] [Related]

  • 13. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon.
    Bouaziz-Borgi L, Almawi WY, Mtiraoui N, Nsiri B, Keleshian SH, Kreidy R, Louzir B, Hezard N, Mahjoub T.
    Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of H1299R polymorphism in the Factor V gene among the Taif-Saudi Arabia population using polymerase chain reaction-reverse hybridization technique.
    Awad NS, El-Tarras Ael-S.
    Mol Biol Rep; 2012 Jan; 39(1):439-43. PubMed ID: 21553052
    [Abstract] [Full Text] [Related]

  • 15. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study.
    Zammiti W, Mtiraoui N, Mercier E, Abboud N, Saidi S, Mahjoub T, Almawi WY, Gris JC.
    Thromb Haemost; 2006 Apr; 95(4):612-7. PubMed ID: 16601830
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK, Radaideh AM, Ababneh NA, Qaqish BM, Alzoubi R, Khader Y, Mersa JY, Irshaid NM, El-Khateeb M.
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?
    Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A.
    Thromb Haemost; 2001 Aug; 86(2):723-4. PubMed ID: 11522037
    [No Abstract] [Full Text] [Related]

  • 18. Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
    Aras O, Hanson NQ, Tsai MY, Key NS.
    Thromb Haemost; 2002 Jan; 87(1):173-4. PubMed ID: 11848451
    [No Abstract] [Full Text] [Related]

  • 19. Factor-V HR2 haplotype and thromboembolic disease.
    Aleksova A, Di Nucci M, Gobbo M, Bevilacqua E, Pradella P, Salam K, Barbati G, De Luca A, Mascaretti L, Sinagra G.
    Acta Cardiol; 2015 Dec; 70(6):707-11. PubMed ID: 26717220
    [Abstract] [Full Text] [Related]

  • 20. Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders.
    Strey RF, Siegemund A, Siegemund T, Schubert C, Schuster G, Wulff K, Herrmann FH.
    Pathophysiol Haemost Thromb; 2005 Dec; 34(6):279-83. PubMed ID: 16772740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.